S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees

Salesforce (CRM) Price Target & Analyst Ratings

$190.17
-1.10 (-0.58%)
(As of 08/5/2022 08:48 PM ET)
Add
Compare
Today's Range
$186.28
$191.80
50-Day Range
$159.85
$191.27
52-Week Range
$154.55
$311.75
Volume
4.09 million shs
Average Volume
7.36 million shs
Market Capitalization
$189.22 billion
P/E Ratio
184.63
Dividend Yield
N/A
Price Target
$270.53

Salesforce Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 39 Analyst Ratings

Consensus Analyst Price Target

$270.53
42.25% Upside
High Prediction$375.00
Average Prediction$270.53
Low Prediction$175.00
TypeCurrent
8/8/21 to 8/8/22
1 Month Ago
7/9/21 to 7/9/22
3 Months Ago
5/10/21 to 5/10/22
1 Year Ago
8/8/20 to 8/8/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
34 Buy rating(s)
34 Buy rating(s)
33 Buy rating(s)
27 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$270.53$271.32$301.74$279.81
Predicted Upside42.25% Upside27.68% Upside26.42% Upside20.59% Upside
Get Salesforce Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CRM and its competitors with MarketBeat's FREE daily newsletter.


CRM Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Salesforce Stock vs. The Competition

TypeSalesforceComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.92
2.59
2.50
Consensus RatingModerate BuyBuyHold
Predicted Upside42.25% Upside101.60% Upside18.64% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
3052
86.00%
Underperform Votes
497
14.00%
Avg. Outperform Votes
224
67.07%
Avg. Underperform Votes
110
32.93%
Avg. Outperform Votes
840
68.74%
Avg. Underperform Votes
382
31.26%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/18/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$250.00 ➝ $220.00+31.44%
6/17/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brian Schwartz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$205.00+25.17%
6/3/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$192.00+3.83%
6/2/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$225.00 ➝ $175.00-0.61%
6/1/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Bhatia
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
6/1/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$260.00 ➝ $225.00+40.41%
6/1/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$300.00 ➝ $250.00+56.02%
6/1/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$300.00 ➝ $260.00+62.26%
6/1/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$225.00 ➝ $235.00+46.66%
6/1/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$316.00 ➝ $275.00+71.62%
6/1/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$300.00 ➝ $250.00+56.02%
6/1/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$300.00 ➝ $260.00+62.26%
6/1/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$375.00 ➝ $315.00+96.58%
6/1/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$208.00 ➝ $218.00+36.05%
5/23/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Thill
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Target$330.00 ➝ $260.00+61.49%
5/23/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$285.00 ➝ $225.00+39.75%
5/18/2022Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Baldry
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$242.00+48.88%
5/18/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$295.00 ➝ $225.00+37.42%
5/17/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Karl Keirstead
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNA$225.00 ➝ $185.00+12.72%
5/16/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$360.00 ➝ $291.00+74.35%
5/12/2022OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradePositive
5/9/2022CICC Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform
4/25/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$281.00 ➝ $223.00+30.08%
3/2/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Hynes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$315.00 ➝ $260.00+23.45%
3/2/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jaluria Rishi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$325.00+57.48%
3/2/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rangan Kash
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetBuy$340.00 ➝ $360.00+74.44%
3/2/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy$360.00 ➝ $300.00+46.67%
3/2/2022Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$315.00 ➝ $275.00+31.65%
12/12/2021Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$375.00+40.96%
12/1/2021Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Terry Tillman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$315.00 ➝ $330.00+25.21%
11/22/2021Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$360.00+23.53%
9/24/2021Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brian White
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSell ➝ Buy$300.00 ➝ $328.00+18.05%
9/24/2021JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Patrick Walravens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$320.00 ➝ $325.00+16.97%
9/14/2021Nord/LB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Donie Wolfgang
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$275.00+8.12%
8/27/2021Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$290.00 ➝ $321.00+19.87%
8/26/2021Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$266.00 ➝ $290.00+5.97%
8/26/2021FBN Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$290.00 ➝ $310.00+13.28%
8/26/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$290.00 ➝ $300.00+9.87%
8/26/2021KGI Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$330.00+26.51%
6/28/2021Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy ➝ Buy$320.00+32.30%
2/26/2021Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$252.00 ➝ $273.00+24.09%
12/2/2020Pritchard Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$300.00 ➝ $250.00+3.58%
11/17/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$304.00+18.93%
6/1/2020Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy$222.00 ➝ $225.00+28.71%
5/29/2020Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold
5/22/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Terry Tillman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$210.00+18.08%
5/4/2020Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell
2/28/2020Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Logan Purk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
2/27/2020Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive ➝ Buy$180.00 ➝ $215.00+20.20%
12/5/2019Cross Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Outperform
12/4/2019Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Robert Breza
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$185.00+14.50%
11/13/2019Piper Jaffray Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$190.00+16.85%
8/23/2019Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
James Rutherford
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetBuy$184.00+18.61%
8/23/2019Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Marshall Senk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set TargetBuy$193.00+24.41%
8/23/2019Nomura Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Christopher Eberle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$180.00 ➝ $185.00+24.80%
(Data available from 8/8/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Salesforce Price Target - Frequently Asked Questions

What is Salesforce's consensus rating and price target?

According to the issued ratings of 39 analysts in the last year, the consensus rating for Salesforce stock is Moderate Buy based on the current 4 hold ratings, 34 buy ratings and 1 strong buy rating for CRM. The average twelve-month price prediction for Salesforce is $270.53 with a high price target of $375.00 and a low price target of $175.00. Learn more on CRM's analyst rating history.

Do Wall Street analysts like Salesforce more than its competitors?

Analysts like Salesforce more than other Computer and Technology companies. The consensus rating for Salesforce is Moderate Buy while the average consensus rating for computer and technology companies is Buy. Learn more on how CRM compares to other companies.

Do MarketBeat users like Salesforce more than its competitors?

MarketBeat users like Salesforce more than other Computer and Technology companies. 86.00% of MarketBeat users gave Salesforce an outperform vote while computer and technology companies recieve an average of 67.08% outperform votes by MarketBeat users.

Is Salesforce being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Salesforce's stock had 1 upgrade and 1 downgrade by analysts.

Does Salesforce's stock price have much upside?

According to analysts, Salesforce's stock has a predicted upside of 27.20% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:CRM) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.